Developed in conjunction with

April, 2014
SOM Biotech and The Vall d'Hebron Institute of...
March, 2014
SOM Biotech attended Bio-Europe Spring 2014 in Turin. 2,000 high-level executives from pharma, biotech, venture capital...

July, 2013

SOM has licensed to the biotech  ARGON Pharma  a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.